Alexander Azoy Arcus Biosciences, Inc. (RCUS) insider trading activity

Alexander Azoy is Chief Accounting Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 18,531 shares of RCUS, which is worth approximately $371,917. The most recent transaction as insider was on Dec 18, 2025, when has been sold 4,343 shares (Common Stock) at a price of $22.25 per share, resulting in proceeds of $96,631. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.5K

32.28% 3M change

41.52% 12M change

Total Value Held $371,917

Alexander Azoy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2025	SELL Open market or private sale	$96,631 $22.25 p/Share	4,343 Reduced 18.99%	18,531 Common Stock
Dec 17 2025	SELL Open market or private sale	$46,824 $22.16 p/Share	2,113 Reduced 8.46%	22,874 Common Stock
Dec 16 2025	SELL Open market or private sale	$51,986 $21.88 p/Share	2,376 Reduced 8.68%	24,987 Common Stock
Nov 26 2025	SELL Open market or private sale	$49,400 $26.0 p/Share	1,900 Reduced 6.49%	27,363 Common Stock
Nov 26 2025	BUY Exercise of conversion of derivative security	$25,327 $13.33 p/Share	1,900 Added 6.1%	29,263 Common Stock
Sep 29 2025	SELL Open market or private sale	$36,803 $13.0 p/Share	2,831 Reduced 9.38%	27,363 Common Stock
Sep 05 2025	SELL Open market or private sale	$18,758 $11.88 p/Share	1,579 Reduced 4.97%	30,194 Common Stock

Jan 23 2025	BUY Grant, award, or other acquisition	-	17,100 Added 36.16%	30,194 Common Stock
Dec 19 2024	SELL Sale (or disposition) back to the issuer	$45,616 $15.17 p/Share	3,007 Reduced 18.68%	13,094 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$47,741 $16.08 p/Share	2,969 Reduced 15.57%	16,101 Common Stock
Dec 02 2024	SELL Open market or private sale	$3,079 $15.32 p/Share	201 Reduced 1.04%	19,070 Common Stock
Aug 13 2024	SELL Open market or private sale	$20,314 $14.97 p/Share	1,357 Reduced 6.64%	19,070 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	8,850 Added 31.7%	19,070 Common Stock
Dec 20 2023	SELL Sale (or disposition) back to the issuer	$1,238 $18.21 p/Share	68 Reduced 0.66%	10,220 Common Stock
Dec 19 2023	SELL Sale (or disposition) back to the issuer	$11,957 $18.09 p/Share	661 Reduced 6.04%	10,288 Common Stock
Dec 18 2023	SELL Sale (or disposition) back to the issuer	$11,477 $17.74 p/Share	647 Reduced 5.58%	10,949 Common Stock
Dec 01 2023	SELL Open market or private sale	$4,215 $14.95 p/Share	282 Reduced 2.37%	11,596 Common Stock
Jul 03 2023	SELL Open market or private sale	$20,777 $20.41 p/Share	1,018 Reduced 8.07%	11,596 Common Stock

Alexander Azoy

Chief Accounting Officer

Hayward, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCUS shares.

Notify only if

Value

Insider Trading

Get notified when an Arcus Biosciences, Inc. insider buys or sells RCUS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcus Biosciences, Inc.

Track Activities on RCUS

Account